- Home
- R vs IONS Comparison
R vs IONS Comparison
Compare R & IONS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- R
- IONS
- Stock Information
- Founded
- R 1933
- IONS 1989
- Country
- R United States
- IONS United States
- Employees
- R N/A
- IONS N/A
- Industry
- R Rental/Leasing Companies
- IONS Biotechnology: Pharmaceutical Preparations
- Sector
- R Consumer Discretionary
- IONS Health Care
- Exchange
- R Nasdaq
- IONS Nasdaq
- Market Cap
- R 7.0B
- IONS 6.0B
- IPO Year
- R N/A
- IONS 1991
- Fundamental
- Price
- R $143.72
- IONS $30.17
- Analyst Decision
- R Buy
- IONS Buy
- Analyst Count
- R 6
- IONS 19
- Target Price
- R $164.40
- IONS $59.24
- AVG Volume (30 Days)
- R 386.3K
- IONS 1.5M
- Earning Date
- R 04-23-2025
- IONS 05-06-2025
- Dividend Yield
- R 2.25%
- IONS N/A
- EPS Growth
- R 26.57
- IONS N/A
- EPS
- R 11.05
- IONS N/A
- Revenue
- R $12,636,000,000.00
- IONS $705,138,000.00
- Revenue This Year
- R $5.27
- IONS N/A
- Revenue Next Year
- R $6.10
- IONS $25.71
- P/E Ratio
- R $13.01
- IONS N/A
- Revenue Growth
- R 7.24
- IONS N/A
- 52 Week Low
- R $106.88
- IONS $29.61
- 52 Week High
- R $171.78
- IONS $52.34
- Technical
- Relative Strength Index (RSI)
- R 43.05
- IONS 37.05
- Support Level
- R $138.67
- IONS $31.04
- Resistance Level
- R $146.73
- IONS $33.76
- Average True Range (ATR)
- R 4.87
- IONS 1.16
- MACD
- R 0.55
- IONS -0.30
- Stochastic Oscillator
- R 77.78
- IONS 10.92
About R Ryder System Inc.
Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.
About IONS Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024.